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Interdialytic weight gain in patients on hemodialysis is associ-
ated with dry mouth and thirst.
Background. Patients receiving hemodialysis (HD) have to
maintain a fluid-restricted diet. Severe thirst can induce non-
compliance to this diet, resulting in an increase of interdialytic
weight gain (IWG = weight predialysis − postdialysis) asso-
ciated with poor patient outcomes. Because oral dryness may
contribute to experienced thirst, we investigated the possible re-
lation between thirst, salivary flow rate, xerostomia, and IWG.
Methods. Unstimulated (UWS) and stimulated (CH-SWS)
whole saliva were collected from 94 HD patients (64 men, 54.8 ±
15.5 years; 30 women, 59.5±18.7 years). Secretion rates of saliva
were determined gravimetrically. Xerostomia was assessed with
a validated Xerostomia Inventory (XI), and thirst with a newly
developed Dialysis Thirst Inventory (DTI).
Results. Before dialysis, 36.2% of the patients had hypos-
alivation (UWS ≤0.15 mL/min). The XI scores had a positive
relation with IWG (r = .250, P < 0.001). Gender and age differ-
ences were observed for thirst, salivary flow rates, and xerosto-
mia. The prevalence and severity of thirst and xerostomia were
greater in younger subjects. Patients with urine output did not
differ from those without urine output with respect to thirst,
xerostomia, and IWG. Correlations were found between thirst
(DTI) and both IWG and xerostomia (XI) (r = .329, P < 0.001,
respectively; r = .740, P < 0.001). Other correlations were ob-
served between xerostomia and both the salivary flow rate and
total number of medications (r = −.252, P < 0.05, respectively;
r = .235, P <.05).
Conclusion. In HD patients, xerostomia (XI) and thirst (DTI)
are associated with a higher IWG. Our data provide evidence
that, in HD patients, xerostomia is related to both salivary flow
rate and thirst (DTI).
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Patients with end-stage renal disease (ESRD) on
hemodialysis (HD) have to maintain a fluid-restricted
diet to prevent fluid overload [1]. During hemodialy-
sis excess fluid is removed to normalize extracellular
fluid volume and blood pressure. For many HD patients,
however, it is difficult to adhere to this fluid restriction.
Chronic fluid overload can result in hypertension, acute
pulmonary edema, congestive heart failure, and prema-
ture death [2–6]. The interdialytic weight gain (IWG) is
an indicator of compliance to the fluid-restricted diet, and
is influenced by social and psychologic factors, but fore-
most by physical factors like excessive thirst [3, 4, 6–8].
Thirst or “the urge to drink” is affected by many differ-
ent factors, including sodium intake, high plasma sodium,
potassium depletion, angiotensin II, acute increases in
plasma urea, low dry weight (postdialysis hypovolemia),
and psychologic factors [7–10]. Besides thirst, a subjec-
tive feeling of a dry mouth (xerostomia) could also be
a potential important stimulus for water intake [11–13].
Patients with xerostomia caused by radiation therapy, for
example, report an increased water consumption in order
to facilitate eating, articulation, and speech [14]. Xeros-
tomia has also been reported in patients on HD [15]. In
addition, other studies showed impaired saliva secretion
in HD patients compared to healthy control patients [16–
21]. Therefore, it is conceivable that xerostomia is one of
the factors that contributes to the intake of fluid of HD
patients and—consequently—to the IWG. The aim of the
present study was to establish whether aspects of oral dry-
ness, in particular, salivary flow rate and xerostomia, are
related to thirst and IWG in HD patients.
METHODS
Participants
ESRD patients undergoing HD for at least three
months were recruited from four different dialysis
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Table 1. Clinical data (N = 94)
Mean (SD) Range
Mean age years 56.4 (16.7) 20–85
Mean time since first dialysis months 35.8 (31.0) 3–188
Mean IWG kg 2.2 (1.3) 0.0–5.6
Mean Kt/V 3.6 (1.1) 0.9–6.0
Mean SBP mm Hg 146 (22) 90–195
Mean DBP mm Hg 81 (13) 50–113
Mean number of systemic medication N 9.8 (3.7) 3–18
Mean number of xerogenic medication N 1.0 (1.0) 0–4
Abbreviations are: IWG, interdialytic weight gain; Kt/V, removal of urea by
dialysis a week; V, volume of distribution of urea estimated as 55% of body
weight; SBP, systolic blood pressure.
centers. Ninety-four patients on HD gave informed con-
sent for this study, which was approved by the Medi-
cal Ethical Committee of the Vrije Universtiteit Medical
Center, Amsterdam, The Netherlands.
Age, gender, level of education, ethnic background,
smoking habits, and use of alcohol were assessed with
a questionnaire. Clinical data with regard to HD were
retrieved from patient files in each participating cen-
ter and are presented in Table 1. The pathology caus-
ing the chronic renal failure was classified according to
the European Dialysis and Transplantation Association-
European Renal Association [22]. The medication of
the patients was categorized as potentially causing sali-
vary hypofunction (putatively xerogenic) or not (non-
xerogenic) [23, 24]. Patients were weighed before and
after a dialysis session. IWG was defined as the amount
of fluid (kg) removed during the session (weight predial-
ysis minus weight postdialysis) with the assumption that
all the weight gained in the previous interdialytic interval
was lost during the dialysis session [5, 25].
Saliva collection
Unstimulated and chewing-stimulated saliva samples
were collected before HD. All subjects were instructed to
refrain from smoking, eating, drinking, and tooth brush-
ing for one hour prior to the saliva collection.
Unstimulated whole saliva (UWS) was collected ac-
cording to the spitting method [26], with some small
modifications [27]. Several minutes before collection, the
participants rinsed their mouth with tap water. The col-
lection started with the instruction to void the mouth of
saliva by swallowing. Subsequently, saliva was allowed
to accumulate in the floor of the mouth, and the sub-
jects were instructed to spit out into preweighed test
tubes every 30 seconds. The saliva collection period was
five minutes.
Chewing-stimulated whole saliva (CH-SWS) was col-
lected for five minutes using a tasteless piece of parafilm
(5 × 5 cm; 0.30 g; Parafilm “M,” American National CAL,
Chicago, IL, USA). During the saliva collection period,
the subjects chewed at their natural pace. The mechani-
Table 2. Items of the Dialysis Thirst Inventory (DTI) and the
Xerostomia Inventory (XI), the proportion of patients’ answers (%)
for each item divided in three categories
Never/
almost Fairly often/
Xerostomia Inventory never Occasionally very often
I sip liquid to aid in 38.7 29.0 32.3
swallowing food
My mouth feels dry 57.0 21.5 21.5
when eating a meal
I get up at night to drink 53.8 24.7 21.6
My mouth feels dry 25.8 44.1 30.1
I have difficulty in 47.8 20.7 31.6
eating dry foods
I suck sweets or cough 53.3 21.7 25.0
drops to relieve dry mouth
I have difficulties 67.0 22.0 10.0
swallowing certain foods
The skin of my face feels dry 44.0 18.7 37.4
My eyes feel dry 65.6 19.4 15.0
My lips feel dry 30.1 34.4 35.5
The inside of my nose feels dry 62.6 20.9 16.5
Dialysis Thirst Inventory
Thirst is a problem for me 30.4 30.4 39.1
I am thirsty during the day 14.1 38.0 47.8
I am thirsty during the night 43.5 27.2 29.3
My social life is influenced 61.9 15.2 22.8
because of my thirst feelings
I am thirsty before dialysis 35.1 23.4 41.6
I am thirsty during dialysis 48.1 27.3 24.7
I am thirsty after dialysis 48.1 22.1 29.9
cally stimulated saliva was also spit out into preweighed
test tubes every 30 seconds for five minutes.
Saliva volumes were determined gravimetrically (as-
suming 1 g = 1 mL).
Salivary hypofunction was defined as ≤0.15 mL/min
UWS [28].
Assessment of xerostomia and thirst
During the dialysis session, all participants completed
the Dutch translation of the validated Xerostomia Inven-
tory (XI), which consists of 11 items, each with a five-point
Likert-scale (never = 1, to very often = 5), see Table 2
[29, 30]. Examples of items from the XI are “My mouth
feels dry . . .” “I have difficulty in eating dry foods . . .” and
“I sip liquids to aid in swallowing food.” The responses
to the 11 items were summed, which resulted in an indi-
vidual XI score for each patient that ranged from 11 (no
dry mouth) to 55 (extremely dry mouth).
The Dialysis Thirst Inventory (DTI) is newly devel-
oped and is used to quantify the perceived thirst. The
DTI is a questionnaire with seven items (see Table 2).
Each items has a five-point Likert type scale (never = 1,
to very often = 5). The scores are summed, and provide
a DTI score ranging from seven (no thirst) to 35 (very
thirsty). In order to determine whether the items of the
DTI represented one construct, a factorial analysis was
carried out. This revealed one factor with an Eigen value
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Table 3. Mean flow rate ± SD of the unstimulated (UWS) and
chewing-stimulated salivary flow rate (CH-SWS)
UWS CH-SWS
mL/ mL/
min (SD) min (SD) N
Gender
Male 0.34 (0.23)a 1.19 (0.69)a 64
Female 0.21 (0.21) 0.75 (0.64) 30
Age group
≤64 years 0.32 (0.25) 1.12 (0.73) 63
>65 years 0.25 (0.14) 0.92 (0.62) 31
Edentulous
No 0.31 (0.24) 1.10 (0.74) 71
Yes 0.26 (0.13) .89 (0.54) 22
Diabetic
No 0.30 (0.22) 1.09 (0.71) 80
Yes 0.30 (0.26) 0.81 (0.61) 13
Urine output
No 0.30 (0.23) 1.06 (0.77) 68
Yes 0.30 (0.21) 1.04 (0.52) 26
Xerogenic medication
0 0.29 (0.19) 1.08 (0.68) 36
1 0.32 (0.26) 1.04 (0.76) 32
2 0.33 (0.26) 1.14 (0.69) 17
>3 0.25 (0.11) 0.90 (0.70) 8
Smoking status
Non-smoker 0.28 (0.22) 1.00 (0.69) 73
Smoker 0.38 (0.24) 1.31 (0.77) 17
Alcohol consumption
No 0.28 (0.23) 1.09 (0.79) 52
Yes 0.32 (0.22) 1.02 (0.60) 39
Time dialysis
≤24 months 0.31 (0.20) 1.19 (0.58) 34
>24 months 0.29 (0.24) 0.98 (0.76) 59
aP < 0.01.
of 3.98, which explained 56.9% of the variance of the
items. The Chronbach’s alpha for the DTI was 0.87.
When the subjects reported “occasionally” until “very
often” on an item from either the XI or DTI, it was
judged as ‘present.’ In all other cases, “never” and “al-
most never” were judged as ‘absent.’
Statistical methods
Data are presented as mean ± SD. UWS and CH-SWS
flow rates showed a skewed distribution, and were log-
arithmically transformed (log10) before statistical anal-
yses. For readability, the original (untransformed) data
are presented in Table 3. Normally distributed data (DTI
and XI score) and the logarithmically transformed data
were analyzed with independent Student t tests. Corre-
lations between XI, DTI, IWG, and the logarithmically
transformed UWS flow rates were subjected to Pearson’s
product-moment correlation analysis. To further explore
relationships between IWG and both thirst (DTI score)
and xerostomia (XI score), partial correlation coeffi-
cients were calculated after controlling for XI and DTI,
respectively.
The main dependent variables (IWG, DTI score, XI
score, salivary flow rates) were subjected to a univari-
ate analysis of variance (ANOVA), with gender, age
(≤64 years, >65 years), alcohol use, and smoking habits
as factors. Potential interactions between these variables
were explored using a full factorial model (two-way
ANOVA). The statistical analysis was performed using
the statistical software package SPSS (version 10.0, SPSS,
Inc., Chicago, IL, USA). All levels of significance were
set at P < 0.05.
RESULTS
Patient demographics
The total sample of this study comprised 94 HD pa-
tients, 64 men (mean age 54.8 ± 15.5 years) and 30 women
(mean age 59.5 ± 18.7 years). The mean time of treat-
ment with HD was 35.8 ± 31.0 months. The causes of
chronic renal failure in the study group were renal vas-
cular disease due to hypertension (16.0%), polycystic
kidneys adult type (11.7%), glomerulonephritis (10.6%),
miscellaneous (22.3%), and unknown (39.4%). In total,
13 patients suffered from diabetes mellitus (type 1 or 2),
which was the cause of the chronic renal failure in five
individuals.
The main categories of putatively xerogenic medi-
cation used by the HD patients were antihistamines
(24.2%) and antihypertensives (21.1%). The IWG of the
patients was 2.2 ± 1.3 kg. The average systolic and di-
astolic blood pressure were 146 ± 22 and 81 ± 13 mm
Hg, respectively (Table 1). The mean normalized protein
catabolic rate was 1.1 ± 0.2 g/kg/day and correlated sig-
nificantly with IWG (r = 0.291, P = 0.033).
Saliva secretion
The mean salivary flow rates of UWS and CH-SWS
were 0.30 ± 0.22 mL/min and 1.05 ± 0.70 mL/min, respec-
tively. Normal values (0.25–0.50 mL/min) were reported
in 34.2% of the patients, and hyposalivation (UWS <0.15
mL/min) was found in 36.2% of the cases [28].
Stratified data of the salivary flow rates are presented
in Table 3. Male patients had significantly higher sali-
vary flow rates than females, both for UWS and CH-SWS
(P < 0.001). No diurnal differences in secretion rates were
observed between patients who were treated in the morn-
ing versus the afternoon (data not shown). No significant
differences in UWS and CH-SWS were observed with re-
gard to age, dental status (dentate vs. edentulous), diabet-
ics, urine output, alcohol consumption, smoking, or total
time on dialysis. No significant association was observed
between the number of putatively xerogenic medications
used and the UWS flow rate (r = −0.018, P = 0.914).
Xerostomia (Xerostomia Inventory)
The mean XI score of the study population was 28.3 ±
9.1. Significant differences were observed with regard to
gender, age, and alcohol consumption (Table 4). Women
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Table 4. Mean XI score ± SD (Xerostomia Inventory) and DTI
score ± SD (Dialysis Thirst Inventory).
XI score (SD) DTI score (SD)
(range 11–55) (range 7–35) N
Gender
Male 26.7 (8.5)a 19.3 (6.6) 60
Female 31.6 (9.7) 22.2 (8.4) 28
Age group
≤64 years 31.4 (9.1)b 22.2 (6.5)b 49
>65 years 23.1 (7.7) 16.7 (7.7) 23
Edentulous
No 29.1 (8.7) 21.0 (6.7) 65
Yes 25.7 (10.1) 18.1 (9.0) 22
Diabetic
No 27.7 (8.6) 20.8 (7.7) 76
Yes 31.5 (12.0) 20.2 (7.3) 12
Urine output
No 28.8 (9.1) 20.5 (7.3) 64
Yes 26.8 (9.3) 19.8 (7.7) 24
Xerogenic medication
0 28.2 (8.5) 19.9 (7.2) 32
1 28.5 (9.5) 21.3 (7.3) 32
2 26.9 (9.5) 20.0 (8.5) 16
>3 28.6 (13.3) 18.7 (7.4) 7
Smoking status
Nonsmoker 28.4 (8.8) 20.3 (7.2) 71
Smoker 27.3 (10.8) 20.7 (8.5) 16
Alcohol consumption
No 30.0 (10.0)a 21.4 (7.8) 49
Yes 25.9 (7.4) 18.8 (6.7) 38
Time dialysis
≤24 months 26.1 (8.3) 18.0 (7.4) 34
>24 months 29.6 (9.4) 21.6 (7.1)a 54
aP < 0.05; bP < 0.01.
had higher XI scores (31.6 ± 9.7) than men (26.7 ± 8.5;
P = 0.019). Participants older than 65 years reported sig-
nificant lower XI scores (23.1 ± 7.7) than subjects below
the age of 65 years (31.4 ± 9.1; P < 0.0005). In 74.2%
of the patients a subjective dry mouth was present. A
small majority of the study population (52.3%) reported
to have problems with eating dry food, and 61.3% of the
patients sipped liquids to aid in swallowing food.
The total number of all medications used was positively
correlated with the XI score (r = 0.257, P = 0.016). How-
ever, no significant association was found between the
number of putatively xerogenic medications used and the
XI score (r = 0.039, P = 0.717). A large difference was ob-
served between female patients who smoked (DTI score:
32.0 ± 4.2) and nonsmoking patients (21.3 ± 8.0). In con-
trast, no difference was observed between male smokers
and nonsmokers.
Thirst (Dialysis Thirst Inventory)
The mean DTI score of the patients was 20.3 ± 7.3. Pa-
tients over the age of 65 years had significantly lower DTI
scores than subjects younger than 65 years (16.7 ± 7.7 and
22.2±6.5, respectively; P <0.0005) (see Table 4). Patients
>24 months on dialysis reported more thirst (DTI score:
21.6 ± 7.1) than patients ≤24 months on dialysis (DTI
Xerostomia
IWG
Flow rate
Thirst
.736** .376**
.003
−.227*
−.298**
.250*
Fig. 1. Pearson correlations between xerostomia (XI score), thirst
(DTI score), and flow rate (UWS) and interdialytic weight gain (IWG).
∗P < 0.05, ∗∗P < 0.01.
score: 18.0 ± 7.4). Table 2 gives an overview of the scores
for each item of the DTI. Of the patients, 39.1% reported
thirst as a problem (fairly to very often). During daytime,
47.8% of the patients reported to have thirst. During the
night, the proportion of patients with thirst decreased to
29.3%. In 38.1% of the study group, social life is influ-
enced by thirst. Before a dialysis session, the perceived
thirst is much higher (41.6% ‘fairly often’ or ‘very often’)
than during dialysis (24.7%) or afterwards (29.9%).
A nearly significant association was observed between
the DTI score and the number of medications used (r =
0.212, P = 0.065). Significant two-way interactions for the
DTI score were observed between gender and smoking
[F (1, 65) = 4.63, P < 0.05] and between age and alcohol
[F (1, 65) = 5.91, P < 0.05]. A large difference was found
between female patients who smoked (DTI score: 32.0
± 4.2) and nonsmoking patients (DTI score: 21.3 ± 8.0).
In contrast, no difference was observed between male
smokers and nonsmokers.
Relationships between IWG, thirst, xerostomia,
and saliva secretion
A strong positive correlation between thirst and xeros-
tomia was found (r = 0.736, P < 0.0005; Fig. 1). Thirst and
xerostomia are associated with IWG, as shown by the sig-
nificant correlations of both the XI score and DTI score
with IWG (r = 0.376, P = 0.001 and r = 0.250, P = 0.020
respectively; Figs. 2 and 3). Thirst was inversely and sig-
nificantly correlated with the UWS flow rate (r = −0.227,
P = 0.049). No significant correlation was observed be-
tween UWS flow rate and the IWG.
Partial correlation coefficients between thirst and IWG
remained significant after controlling for the XI score
(r = 0.253, P = 0.031). After controlling for DTI score, the
correlation between xerostomia and IWG was no longer
significant (r = 0.038, P > 0.05). The correlation between
DTI score and XI score remained high after controlling
for IWG (r = 0.700, P < 0.01). No significant interactions
of gender and age with smoking status and alcohol con-
sumption were observed for IWG, thirst, xerostomia, or
salivary flow rate.
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Fig. 2. Relationship between interdialytic weight gain (IWG) and Xe-
rostomia Inventory (XI). Pearson correlation (r = 0.250, P < 0.05).
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Fig. 3. Relationship between interdialytic weight gain (IWG) and Dial-
ysis Thirst Inventory (DTI). Pearson correlation (r = 0.376, P < 0.005).
DISCUSSION
The present study is the first large scale, multicenter
study to investigate whether aspects of oral dryness, es-
pecially salivary flow rate and xerostomia, were related
to thirst and IWG. We indeed found significant relation-
ships between a dry mouth (both xerostomia and reduced
salivary flow rates) and thirst, and xerostomia and IWG.
This suggests a possible role of oral dryness to explain
higher fluid intake between HD sessions, and opens fu-
ture interventions to manipulate dry mouth and/or flow
rates to decrease thirst and IWG in HD patients.
A subjective feeling of a dry mouth (xerostomia) in HD
patients was assessed using a validated xerostomia ques-
tionnaire (XI), with high scores indicating severe com-
plains of oral dryness. We found that the subjective dry
mouth feelings of HD patients (XI = 28.3 ± 9.1) were
similar to patients receiving radiotherapy for head- and-
neck cancer two months after the initial radiotherapy
(XI = 31.4 ± 7.3) [29]. A relatively large proportion of
the HD patients in our study reported having a dry mouth
(76.4%). This is in agreement with previous studies on
HD patients, in which the percentage of patients report-
ing a dry mouth ranged between 32.9% [17] and 66.7%
[18]. Remarkably, no significant association was observed
between the number of putatively xerogenic medications
used and the XI score. The absence of this association
may be either the result of the relatively broad classifica-
tion of putatively xerogenic medication or the interaction
between multiple medications used by HD patients [31].
In our study, the mean XI score of HD patients over
the age of 65 years (XI = 23.1 ± 7.7) is similar to re-
ports of oral dryness in healthy subjects over 65 years
(XI = 20.0 ± 7.0) [31]. However, HD patients under the
age of 65 years have much higher XI scores (31.4 ± 7.7),
which might be explained by a gradual habituation to
a dry mouth over the years. It has been suggested that
younger subjects may also be more likely to experience
symptoms of oral dryness when salivary flow is low, while
in older persons symptoms of dry mouth could be related
to a more complex constellation of factors where salivary
flow is only one component [32]. A large-scale epidemio-
logic survey among an adult population, however, found
a strong positive correlation between age and reports of
a dry mouth [33]. Similarly, in our study, age and gender
differences for the level of xerostomia (XI) and salivary
flow rates (UWS and CH-SWS) in HD patients were ob-
served. This is consistent with previous studies that men
have higher salivary flow rates than women, and women
report more xerostomia [31, 32, 34, 35].
The mean salivary flow rates of both unstimulated
(UWS) and stimulated saliva (CH-SWS) in HD patients
were normal and comparable to reference values for
healthy subjects [36]. However, it should be mentioned
that the original flow rate date was skewed to the right and
had a large standard deviation. Many HD patients have
low salivary flow rates. The calculated mean rates were
normal due to a few HD patients with high flow rates.
The mean UWS in our study was also consistent with the
study of Galvada et al [16], who found an average UWS
flow rate of 0.26 ± 0.28 mL/min in HD patients compared
to control patients (UWS = 0.28 ± 0.16 mL/min). Kho
et al [17] investigated 22 patients undergoing HD and
found an average UWS flow rate of 0.30 ± 0.18 mL/min.
Our observation that the mean CH-SWS of HD pa-
tients was comparable to reference values for healthy sub-
jects [36] differs from previous studies reporting that the
stimulated salivary flow rates were significantly reduced
in HD patients compared to control groups [15, 17, 20,
21]. This could be explained by the fact that in our study
a tasteless piece of parafilm was used to stimulate sali-
vary flow, while previous studies used other mechanical
or chemical stimuli like 2% citric acid. The altered taste
perception of HD patients may also partially contribute
to these different findings [37].
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The salivary flow rate (UWS) and the perception of
a dry mouth (XI) correlated significantly (r = −0.298,
P < 0.05), which is in agreement with previous studies re-
porting a correlation between objective measures of a dry
mouth (salivary flow rate) and subjective reports of a dry
mouth (xerostomia) in patients with rheumatoid arthritis
[38, 39]. Responses to questions related to eating (such
as ‘my mouth feels dry during eating a meal,’ ‘sipping
liquids to aid swallowing,’ and ‘difficulties in swallowing
dry food’) were highly indicative of salivary performance
[40]. However, a subjective dry mouth is not always nec-
essarily related to a reduced salivary flow rate [39–41],
and other factors including anxiety, depression, and stress
might play a role in the perception of a dry mouth [35,
42]. It has been demonstrated that anxiety, depression,
and stress also play a role in the compliance of HD pa-
tients to fluid restriction, measured by the IWG [4].
For this study a new Dialysis Thirst Inventory (DTI)
was developed, focusing on perceived thirst. Significantly
lower thirst scores were observed in the age group over
65 years, which is comparable to reduced complaints of
oral dryness (XI) in the older aged HD patients. Our find-
ings are also in agreement with diminished feelings of
thirst and reduced fluid intake in healthy elderly persons
[43, 44]. Older subjects may have a higher osmotic op-
erating point for thirst sensation, a diminished response
by baroreceptors to volume changes, or adaptation to the
fluid restriction [44].
Several investigators have suggested that the salivary
glands are directly damaged by either uremic involve-
ment or the fluid-restricted diet [15–18, 21]. In the present
study, the salivary flow rates are not influenced by the
duration of HD treatment. This is in agreement with the
study of Bayraktar et al [21], in which no differences in
salivary flow rate were observed between patients on HD
for more or less than 24 months. Also, the large difference
between the unstimulated and stimulated flow rate in our
study indicates that the salivary glands have maintained
their secretory capacity. This all indicates that the sali-
vary glands are probably not damaged by chronic HD
treatment.
Because our study clearly demonstrates that thirst
(DTI) and xerostomia (XI) are associated with greater
IWG, management of thirst and xerostomia is potentially
clinical important in the treatment of HD patients. Pa-
tients on daily HD were less thirsty and also showed less
fluctuation in body fluid volume [45]. In addition, xeros-
tomia can be reduced by either stimulation of the saliva
secretion (mechanical, gustatory, or pharmacologic) or
palliative care using mouthwashes or saliva substitutes
[46–49]. In healthy subjects, gum chewing increases flow
rate to 187% during the first minute of chewing [50] and
gum chewing can—especially in those with low salivary
function—increase unstimulated flow rates, and might
contribute to reduced levels of xerostomia [51]. Regu-
lar use of gum for two weeks resulted even in a long-term
persistent increase in unstimulated salivary secretion rate
and showed to be effective in reducing xerostomia [52].
Also, in patients with advanced cancer, daily use of chew-
ing gum or a saliva substitute showed to be effective in re-
ducing xerostomia [48]. Use of saliva substitutes reduced
dry mouth feelings in patients with irradiation-induced
xerostomia [53]. In a small pilot study, use of a saliva
substitute in HD patients resulted in a reduction of fluid
overload [54].
CONCLUSION
The mean unstimulated and stimulated salivary flow
rates of HD patients in this study are relatively normal.
However, a large proportion of the patients have reduced
unstimulated flow rates. Thirst, IWG, and xerostomia are
associated in HD patients, indicating a possible role of
oral dryness to explain higher fluid intake between HD
sessions. In other studies, the use of saliva stimuli or saliva
substitutes showed to be effective in reducing feelings of
a dry mouth. This might also diminish the urge to drink in
HD patients, enhancing compliance to the fluid-restricted
diet and leading to a decreased IWG and fewer systemic
complications. The potential clinical effect of saliva stim-
uli and saliva substitutes will be investigated in future
studies.
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